← All stocks

Harmony Biosciences Holdings, Inc.

HRMY Net selling

CIK 0001802665 #1965 in the set updated 17 Sep 2026

Bought (1 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (1 mo)

$1.45M

$0.00 on a plan · $1.22M straight out of an exercise

Sold at will

$230.91K

1 of 4 sales

Net

−$1.45M

−$230.91K against sales at will

By person

8 insiders · 4 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Budur Kumar

CHIEF MEDICAL OFFICER

—

$1.45M (4) scheduled

−$1.45M

13,115

0.0225%

$565.27K

+1,205%

Marshman Fund Trust II entity

10% owner

—

6,051,120

10.39%

$260.81M

−43.2%

Kapadia Sandip

CHIEF FINANCIAL OFFICER

—

24,521

0.0421%

$1.06M

+13.7%

Dayno Jeffrey M.

PRESIDENT, CEO

—

7,346

0.0126%

$316.62K

—

Zaeske Adam H.

CHIEF COMMERCIAL OFFICER

—

4,327

0.0074%

$186.50K

—

Serafin Andrew

CHIEF STRATEGY OFFICER

—

1,474

0.0025%

$63.53K

—

Valor IV Pharma Holdings, LLC entity

10% owner

—

0.0000%

$0.00

−100.0%

Dierks Jeffrey

CHIEF COMMERCIAL OFFICER

—

0.0000%

$0.00

—

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 1

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 3

Sales at will 1

Transactions with no price 0

Shares from compensation/vesting 22,954

History held since 20 Aug 2020